Covid-19: Where are we on vaccines and variants?

  title={Covid-19: Where are we on vaccines and variants?},
  author={Elisabeth Mahase},
Nearly a year after WHO declared the covid-19 pandemic, Elisabeth Mahase reports on the latest developments in vaccines, variants, and diplomacy 
Vaccini Covid-19: disponibilità ed efficacia
The Covid-19 vaccination campaign represents a challenge for the health system. Eight Covid-19 vaccines belonging to 4 different categories of technology are currently available. More than theExpand
Covid-19 pandemic: Perspectives on management
Low and middle-income countries must develop links with the WHO COVAX program to ensure global distribution of vaccines, and given the preliminary evidence of the efficacy of over 95%, vaccines are of obvious benefit. Expand
SARS-CoV-2 New Variants: Characteristic Features and impact on the Efficacy of Different Vaccines
  • Abbas Khan, Taimoor Khan, +10 authors Anwar Mohammad
  • Biomedicine & Pharmacotherapy
  • 2021
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its new variants reported in different countries have posed a serious threat to human health and social fabricsExpand
Relevance of immune response and vaccination strategies of SARS-CoV-2 in the phase of viral red queen dynamics
Background Following a relatively mild first wave of coronavirus disease 2019 (COVID-19) in India, a deadly second wave of the pandemic overwhelmed the healthcare system due to the emergence ofExpand
Impact of vaccination on the COVID-19 pandemic: Evidence from U.S. states
The effectiveness of the COVID-19 vaccination program is evaluated and the path to herd immunity in the U.S. is predicted, which is likely to be achieved by the last week of July 2021, with a cumulative vaccination coverage of 60.2%. Expand
The ‘Vero Cell’ COVID-19 vaccine rollout in Nepal: What we know about the Chinese vaccine development and access?
The world has changed dramatically from the impact of the COVID-19. It has impacted the normality of daily life, highlighting the failure of rich and poor nations alike, which is evident from theExpand
Overview of approved and upcoming vaccines for SARS-CoV-2: a living review
Abstract The rapid design and implementation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines is testament to a successfully coordinated global research effort. WhileExpand
Projecting the Impact of SARS-CoV-2 Variants and the Vaccination Program on the Fourth Wave of the COVID-19 Pandemic in South Korea
  • E. Shim
  • Medicine
  • International journal of environmental research and public health
  • 2021
The results indicate that the impact of vaccination can be substantially affected by the emergence of SARS-CoV-2 variants, and herd immunity is unlikely to be achieved with the potential emergence of the Delta variant, inconsistent with the blueprint of the South Korean government. Expand
SARS-CoV-2 variants, spike mutations and immune escape
The literature on mutations of the SARS-CoV-2 spike protein, the primary antigen, is summarized, focusing on their impacts on antigenicity and contextualizing them in the protein structure, and discussed in the context of observed mutation frequencies in global sequence datasets. Expand
The impact of COVID-19 vaccination campaigns accounting for antibody-dependent enhancement
A complex extension of the model underlying the pandemic preparedness tool CovidSim 1.1 is introduced to optimize vaccination strategies with regard to the onset of campaigns, vaccination coverage, vaccination schedules, vaccination rates, and efficiency of vaccines and can serve as a refined decision support tool for COVID-19 management. Expand